Follow
Stéphane Terry
Stéphane Terry
IRSL- Inserm - University Paris-Saclay - Inovarion
Verified email at inserm.fr
Title
Cited by
Cited by
Year
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets
H Beltran, DS Rickman, K Park, SS Chae, A Sboner, TY MacDonald, ...
Cancer discovery 1 (6), 487-495, 2011
9132011
New insights into the role of EMT in tumor immune escape
S Terry, P Savagner, S Ortiz‐Cuaran, L Mahjoubi, P Saintigny, JP Thiery, ...
Molecular oncology 11 (7), 824-846, 2017
3782017
Hypoxia: a key player in antitumor immune response. A review in the theme: cellular responses to hypoxia
MZ Noman, M Hasmim, Y Messai, S Terry, C Kieda, B Janji, S Chouaib
American Journal of Physiology-Cell Physiology 309 (9), C569-C579, 2015
3642015
Inflammation in benign prostatic hyperplasia: a 282 patients' immunohistochemical analysis
G Robert, A Descazeaud, N Nicolaïew, S Terry, N Sirab, F Vacherot, ...
The Prostate 69 (16), 1774-1780, 2009
3552009
The many faces of neuroendocrine differentiation in prostate cancer progression
S Terry, H Beltran
Frontiers in oncology 4, 60, 2014
2632014
Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing
D Pflueger, S Terry, A Sboner, L Habegger, R Esgueva, PC Lin, ...
Genome research 21 (1), 56-67, 2011
2412011
The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200
MZ Noman, B Janji, A Abdou, M Hasmim, S Terry, TZ Tan, ...
Oncoimmunology 6 (1), e1263412, 2017
2302017
Prostate cancer antigen 3 score accurately predicts tumour volume and might help in selecting prostate cancer patients for active surveillance
G Ploussard, X Durand, E Xylinas, S Moutereau, C Radulescu, A Forgue, ...
European urology 59 (3), 422-429, 2011
1902011
FusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNA-sequencing data
A Sboner, L Habegger, D Pflueger, S Terry, DZ Chen, JS Rozowsky, ...
Genome biology 11, 1-19, 2010
1902010
Class III β-tubulin expression predicts prostate tumor aggressiveness and patient response to docetaxel-based chemotherapy
G Ploussard, S Terry, P Maillé, Y Allory, N Sirab, L Kheuang, P Soyeux, ...
Cancer research 70 (22), 9253-9264, 2010
1862010
Oncogene-mediated alterations in chromatin conformation
DS Rickman, TD Soong, B Moss, JM Mosquera, J Dlabal, S Terry, ...
Proceedings of the National Academy of Sciences 109 (23), 9083-9088, 2012
1652012
Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy
JL Campos-Fernandes, L Bastien, N Nicolaiew, G Robert, S Terry, ...
European urology 55 (3), 600-609, 2009
1502009
Complex regulation of human androgen receptor expression by Wnt signaling in prostate cancer cells
X Yang, MW Chen, S Terry, F Vacherot, DL Bemis, J Capodice, ...
Oncogene 25 (24), 3436-3444, 2006
1412006
A human-and male-specific protocadherin that acts through the wnt signaling pathway to induce neuroendocrine transdifferentiation of prostate cancer cells
X Yang, MW Chen, S Terry, F Vacherot, DK Chopin, DL Bemis, ...
Cancer research 65 (12), 5263-5271, 2005
1362005
Multifaceted interaction between the androgen and Wnt signaling pathways and the implication for prostate cancer
S Terry, X Yang, MW Chen, F Vacherot, R Buttyan
Journal of cellular biochemistry 99 (2), 402-410, 2006
1252006
Increased expression of class III β-tubulin in castration-resistant human prostate cancer
S Terry, G Ploussard, Y Allory, N Nicolaiew, F Boissiere-Michot, P Maille, ...
British journal of cancer 101 (6), 951-956, 2009
1132009
The NF-κB/IL-6 pathway in metastatic androgen-independent prostate cancer: new therapeutic approaches?
B Paule, S Terry, L Kheuang, P Soyeux, F Vacherot, A de la Taille
World journal of urology 25, 477-489, 2007
1022007
Prospective evaluation of an extended 21-core biopsy scheme as initial prostate cancer diagnostic strategy
G Ploussard, N Nicolaiew, C Marchand, S Terry, F Vacherot, D Vordos, ...
European urology 65 (1), 154-161, 2014
922014
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets. Cancer Discov. 2011; 1: 487–495. doi: 10.1158/2159-8290
H Beltran, DS Rickman, K Park, SS Chae, A Sboner, TY MacDonald, ...
J Biol Chem 282, 3571-83, 2007
902007
Hypoxic stress-induced tumor and immune plasticity, suppression, and impact on tumor heterogeneity
S Terry, S Buart, S Chouaib
Frontiers in immunology 8, 307077, 2017
852017
The system can't perform the operation now. Try again later.
Articles 1–20